drugset / Trial / NCT02791438
A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety of administration of azilsartan in pediatric patients aged 6 to less than 16 years with hypertension.
Timeline
- Start
- 2016-08-18
- Primary completion
- 2019-06-04
- Completion
- 2019-06-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan | Unknown | 20 mg | Oral |
| Subject | Azilsartan | Unknown | 40 mg | Oral |